0001209191-14-078604.txt : 20141231 0001209191-14-078604.hdr.sgml : 20141231 20141231172347 ACCESSION NUMBER: 0001209191-14-078604 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141231 DATE AS OF CHANGE: 20141231 EFFECTIVENESS DATE: 20141231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PIERIS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001583648 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 300784346 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-231283 FILM NUMBER: 141319066 BUSINESS ADDRESS: STREET 1: LISE-MEITNER-STRASSE 30 CITY: FREISING-WEIHENSTEPHAN STATE: 2M ZIP: 85354 BUSINESS PHONE: 49 81 6114 11400 MAIL ADDRESS: STREET 1: LISE-MEITNER-STRASSE 30 CITY: FREISING-WEIHENSTEPHAN STATE: 2M ZIP: 85354 FORMER COMPANY: FORMER CONFORMED NAME: Marika Inc. DATE OF NAME CHANGE: 20130805 D 1 primary_doc.xml X0707 D LIVE 0001583648 PIERIS PHARMACEUTICALS, INC. 30 Lise-Meitner-Strasse Freising-Weihenstephan 2M GERMANY 85354 4.90816E+13 NEVADA None Marika Inc. Corporation true 2013 Stephen S. Yoder c/o Pieris Pharmaceuticals, Inc., 30 Lise-Meitner-Strasse Freising-Weihenstephan 2M GERMANY 85354 Executive Officer Director Chief Executive Officer and President Darlene M. Deptula-Hicks c/o Pieris Pharmaceuticals, Inc. , 30 Lise-Metner-Strasse Freising-Weihenstephan 2M GERMANY 85354 Executive Officer Acting Chief Financial Officer Chau Khuong c/o Pieris Pharmaceuticals, Inc. , 30 Lise-Metner-Strasse Freising-Weihenstephan 2M GERMANY 85354 Director Chairman of the Board of Directors Christina Takke c/o Pieris Pharmaceuticals, Inc. , 30 Lise-Metner-Strasse Freising-Weihenstephan 2M GERMANY 85354 Director Michael Richman c/o Pieris Pharmaceuticals, Inc. , 30 Lise-Metner-Strasse Freising-Weihenstephan 2M GERMANY 85354 Director Steven Prelack c/o Pieris Pharmaceuticals, Inc. , 30 Lise-Metner-Strasse Freising-Weihenstephan 2M GERMANY 85354 Director Pharmaceuticals Decline to Disclose 06b false 2014-12-17 false true false 2000 Northland Securities, Inc. None Trout Capital LLC 131589 45 S. 7th Street, Suite 2000 Minneapolis MN MINNESOTA 55402 All States Katalyst Securities LLC 112494 American Portfolios Financial Services, Inc. 18487 15 Maiden Lane, Room 601 New York NY NEW YORK 10038 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IN INDIANA IA IOWA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA TX TEXAS VA VIRGINIA Katalyst Securities LLC 112494 Dinosaur Securities, L.L.C. 104446 470 Park Avenue South 9th Floor New York NY NEW YORK 10016 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IN INDIANA IA IOWA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA TX TEXAS VA VIRGINIA 13559020 13559020 0 false 139 1024671 true 0 Two placement agents and their designees received (i) cash commissions in the aggregate of up to 8% of the offerings gross proceeds and (ii) five-year warrants to purchase an aggregate of 8% of the number of shares sold in the offering. 0 false PIERIS PHARMACEUTICALS, INC. /s/ Darlene M. Deptula-Hicks Darlene Deptula-Hicks Acting Chief Financial Officer 2014-12-31